# A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.

> **NCT00576303** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 200 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** methoxy polyethylene glycol-epoetin beta [Mircera]

## Key facts

- **NCT ID:** NCT00576303
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576303, "A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00576303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*